Vascular disease and dementias: Paradigm shifts to drive research in new directions
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Vascular disease was once considered the principal cause of aging‐related dementia. More recently, however, research emphasis has shifted to studies of progressive neurodegenerative disease processes, such as those giving rise to neuritic plaques, neurofibrillary tangles, and Lewy bodies. Although these studies have led to critical insights and potential therapeutic strategies, interest in the role of systemic and cerebrovascular disease mechanisms waned and has received relatively less attention and research support. Recent studies suggest that vascular disease mechanisms play an important role in the risk for aging‐related cognitive decline and disorders. Vascular disease frequently coexists with cognitive decline in aging individuals, shares many risk factors with dementias considered to be of the “Alzheimer type,” and is observed more frequently than expected in postmortem material from individuals manifesting “specific” disease stigmata, such as abundant plaques and tangles. Considerable difficulties have emerged in attempting to classify dementias as being related to vascular versus neurodegenerative causes, and several systems of criteria have been used. Despite multiple attempts, a lack of consensus remains regarding the optimal means of incorporating vascular disease into clinical diagnostic, neurocognitive, or neuropathologic classification schemes for dementias. We propose here an integrative, rather than a strictly taxonomic, approach to the study and elucidation of how vascular disease mechanisms contribute to the development of dementias. We argue that, instead of discriminating between, for example, “Alzheimer's disease,” “vascular dementia,” and other diseases, there is a greater need to focus clinical and research efforts on elucidating specific pathophysiologic mechanisms that contribute to dementia phenotypes and neuropathologic outcomes. We outline a multitiered strategy, beginning with clinical and public health interventions that can be implemented immediately, enhancements to ongoing longitudinal studies to increase their informative value, and new initiatives to capitalize on recent advances in systems biology and network medicine. This strategy will require funding from multiple public and private sources to support collaborative and interdisciplinary research efforts to take full advantage of these opportunities and realize their societal benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“, abnormally folded amyloid peptides [19]) and tangles (i.”
BackgroundAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034 · cited 2×
“Applying emerging principles, methods, and findings of systems biology and network medicine to make optimal use of existing knowledge and generate models of disease processes that will lead to testable hypotheses about the impact of interventions for which sufficient evidence does not yet exist Given the degree of int…”
MethodRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010 · cited 1×
“Intact function of the hemostatic system has a number of beneficial effects, including prevention of excessive bleeding and extravasation of vascular contents into tissue spaces, and vascular repair [138]; however, the cascade of events after sustained or unchecked activation of this system can have deleterious conseq…”
BackgroundJ Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754 · cited 3×
“Recent research has shown that adipocytes produce a wide and complex array of mediators influencing inflammatory processes, insulin resistance, and energy metabolism [104,110,133], many of which have been implicated in the increased risk of atherosclerotic vascular diseases”
Background
Research works printed but not linked: 124
- 10.1016/S0140-6736(09)61460-4 · DOI · Paper page
- 10.2307/3350025 · DOI · Paper page
- 10.1016/j.jalz.2010.01.010 · DOI · Paper page
- 10.1007/s00401-006-0185-2 · DOI · Paper page
- Cavalieri M., 2010, Vascular dementia and Alzheimer's disease—are we in a dead‐end road?, Neurodegener Dis, 7, 122, 10.1159/000285521 · DOI
- 10.1136/jnnp.54.12.1122 · doi:10.1136/jnnp.54.12.1122
- Libon D.J., 2009, Neurovascular Neuropsychology, 75, 10.1007/978-0-387-70715-0_6 · DOI
- Roman G.C., 1999, A historical review of the concept of vascular dementia: lessons from the past for the future, Alzheimer Dis Assoc Disord, 13, S4, 10.1097/00002093-199912001-00002 · DOI
- Roman G.C., 2003, Vascular Cognitive Impairment: Preventable Dementia, 12, 10.1093/oso/9780192632678.003.0002 · doi:10.1093/oso/9780192632678.003.0002
- McMenemey W.H., 1961, Neuropathology, 475
- 10.1001/archneur.1991.00530210089029 · DOI
- Hauw J.J., 1995, Lacunar and Other Subcortical Infarctions, 3
- 10.1056/NEJM198611133152001 · DOI · Paper page
- Lanctôt K.L., 2003, Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta‐analysis, CMAJ, 169, 557
- 10.1016/S0955-0674(05)80038-9 · DOI
- 10.1111/j.1750-3639.1993.tb00725.x · DOI · Paper page
- 10.1146/annurev.med.57.121304.131442 · DOI · Paper page
- 10.1016/0092-8674(89)90093-7 · DOI
- 10.1186/1741-7015-7-7 · DOI · Paper page
- Ganguli M., 2011, Principles and Practice of Geriatric Psychiatry, 207
- 10.1016/S0022-510X(02)00252-6 · DOI · Paper page
- American Psychiatric Association, 1980, Diagnostic and statistical manual of mental diseases, version III
- World Health Organization, 1992, The ICD‐10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
- American Psychiatric Association, 2011, APA DSM‐V
- 10.1176/jnp.2008.20.2.150 · doi:10.1176/jnp.2008.20.2.150 · Paper page
- 10.1176/jnp.2008.20.2.162 · doi:10.1176/jnp.2008.20.2.162 · Paper page
- 10.1159/000026254 · DOI
- 10.1001/archneur.57.2.191 · DOI · Paper page
- Lamar M., 2009, The dysexecutive syndrome associated with ischaemic vascular disease and related subcortical neuropathology: a Boston process approach, Behav Neurol, 22, 53, 10.1155/2010/505979 · DOI · Paper page
- 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
- 10.1097/WAD.0b013e3181a4485c · DOI
- 10.1016/j.neurobiolaging.2008.10.018 · DOI · Paper page
- 10.1001/archneur.65.5.593 · DOI · Paper page
- 10.4997/JRCPE.2011.121 · DOI
- 10.1097/01.JGP.0000231780.44684.7e · DOI
- 10.1161/STROKEAHA.110.605097 · DOI
- 10.1016/j.jns.2005.08.010 · DOI
- 10.1080/13854040500263583 · DOI
- 10.1136/jnnp.67.1.66 · DOI · Paper page
- 10.1212/WNL.44.7.1246 · DOI · Paper page
- 10.1080/09540260902962198 · DOI · Paper page
- 10.1007/s11916-005-0039-y · DOI
- 10.1016/j.jns.2010.08.038 · DOI
- 10.1111/j.1532-5415.1999.tb02571.x · DOI · Paper page
- 10.3233/JAD-2011-091402 · DOI · Paper page
- 10.1002/ana.22055 · DOI · Paper page
- 10.3233/JAD-2009-1180 · DOI · Paper page
- 10.1016/j.neurobiolaging.2008.09.011 · DOI · Paper page
- 10.1016/j.jcomdis.2011.04.004 · DOI · Paper page
- 10.1111/j.1460-9568.2011.07613.x · DOI · Paper page
- 10.1016/B978-0-444-53355-5.00015-4 · DOI · Paper page
- 10.2174/156720511795745302 · DOI
- Williams J.W., 2010, Preventing Alzheimer's disease and cognitive decline. Evidence report/technology assessment
- 10.1161/circ.106.25.3143 · DOI · Paper page
- 10.1177/014107680609900917 · doi:10.1177/014107680609900917
- 10.7326/0003-4819-55-1-33 · DOI · Paper page
- Libby P., 2011, Braunwald's Heart Disease—A Textbook of Cardiovascular Medicine [online version], 914
- 10.1161/01.STR.0000116869.64771.5A · DOI · Paper page
- 10.1038/ajh.2009.212 · DOI · Paper page
- 10.1097/HCO.0b013e3283383e2c · DOI
- 10.1038/nrendo.2010.228 · DOI · Paper page
- 10.2337/diacare.27.5.1047 · DOI · Paper page
- Nichols W.W., 2005, McDonald's blood flow in arteries: theoretical, experimental and clinical principles
- 10.1253/circj.CJ-10-0910 · DOI · Paper page
- Libby P., 2011, Braunwald's Heart Disease—A Textbook of Cardiovascular Medicine [online version], 897
- Lau D.C., 2009, Metabolic syndrome: perception or reality?, Curr Atheroscler Rep, 11, 264, 10.1007/s11883-009-0041-7 · DOI
- 10.1016/j.jns.2010.08.039 · DOI
- 10.3233/JAD-2010-091669 · DOI · Paper page
- 10.1038/oby.2010.59 · DOI · Paper page
- 10.2337/diacare.19.3.287 · DOI · Paper page
- 10.1093/ajcn/83.6.1237 · DOI · Paper page
- 10.1016/j.ecl.2004.12.001 · DOI
- 10.1038/hr.2010.9 · DOI · Paper page
- 10.1038/oby.2010.22 · DOI · Paper page
- 10.1038/ijo.2009.133 · DOI · Paper page
- 10.1080/07853890500383895 · DOI · Paper page
- 10.1002/msj.20212 · DOI · Paper page
- 10.1093/epirev/mxm002 · DOI · Paper page
- 10.1053/j.gastro.2010.04.056 · DOI · Paper page
- 10.1002/path.2912 · DOI · Paper page
- 10.7326/0003-4819-61-5-888 · DOI · Paper page
- 10.1016/S0735-1097(02)02051-X · DOI · Paper page
- 10.1161/CIRCULATIONAHA.108.816694 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.104.475715 · DOI · Paper page
- 10.1007/s11883-011-0166-3 · DOI
- 10.1038/nrcardio.2010.222 · DOI · Paper page
- 10.1007/s11886-010-0136-3 · DOI
- 10.1001/archneurol.2010.297 · DOI · Paper page
- Lesser G.T., 2009, Serum lipids are related to Alzheimer's pathology in nursing home residents, Dement Geriatr Cogn Disord, 27, 42, 10.1159/000189268 · DOI
- 10.1007/s00011-009-0060-4 · DOI · Paper page
- 10.2741/3812 · DOI
- 10.1046/j.1365-2796.2003.01177.x · DOI · Paper page
- 10.1007/s11906-008-0029-7 · DOI · Paper page
- 10.1007/s11883-007-0009-4 · DOI
- 10.1007/s11906-010-0096-4 · DOI · Paper page
- 10.1038/nature05485 · DOI · Paper page
- 10.1056/NEJMra1011670 · DOI · Paper page
- Konkle B.A., 2011, Harrison's Principles of Internal Medicine
- Weitz J.I., 2011, Braunwald's Heart Disease—A Textbook of Cardiovascular Medicine [online version], 1844
- 10.1172/JCI27196 · DOI · Paper page
- Alessi M.C., 2008, Metabolic syndrome, haemostasis and thrombosis, Thromb Haemost, 99, 995, 10.1160/TH07-11-0682 · DOI · Paper page
- Palomo I., 2010, Pathophysiology of the proatherothrombotic state in the metabolic syndrome, Front Biosci (Schol Ed), 2, 194
- Steg P.G., 2011, Atherothrombosis and the role of antiplatelet therapy, J Thromb Haemost, 9, 325, 10.1111/j.1538-7836.2011.04277.x · DOI
- 10.1161/ATVBAHA.109.199448 · DOI
- 10.1042/CS20100094 · DOI · Paper page
- 10.1007/s00401-010-0652-7 · DOI · Paper page
- 10.1007/s00401-009-0501-8 · DOI · Paper page
- 10.3988/jcn.2011.7.1.1 · DOI · Paper page
- Magistretti P.J., 2000, Psychopharmacology–4th Generation of Progress
- 10.1016/S0079-6123(06)53007-9 · DOI · Paper page
- PaseMP HerbertA GrimaNA Pipingas A O'RourkeMF.Arterial stiffness as a cause of cognitive decline and dementia: a systematic review and meta‐analysis.Intern Med J(in press).
- 10.1111/j.1749-6632.1994.tb44398.x · DOI · Paper page
- 10.1007/s00401-011-0865-4 · DOI · Paper page
- 10.1007/s00401-009-0522-3 · DOI · Paper page
- 10.1007/s12035-010-8105-9 · DOI · Paper page
- Grammas P., 2011, Brain microvasculature and hypoxia‐related proteins in Alzheimer's disease, Int J Clin Exp Pathol, 4, 616
- 10.1007/s00018-009-0141-0 · DOI
- 10.1096/fj.11-0102ufm · DOI · Paper page
- 10.1111/j.1749-6632.2010.05760.x · DOI · Paper page
- Institute of Medicine, 2001, Crossing the Quality Chasm: a new health system for the 21st century
- 10.1377/hlthaff.2010.0696 · DOI
- 10.1016/S1474-4422(11)70072-2 · DOI · Paper page
- 10.1017/S0033291711000109 · DOI · Paper page
Cited by
Alzheimer’s disease: risk factors and potentially protective measures
Silva, M. V. F., Loures, C. D. M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Carvalho, M. D. G. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0524-y · Cited by 937
Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849
Self-citationThe overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“Therefore, an integrating rather than a strictly taxonomic approach (instead of discriminating AD, VaD, and other diseases) to elucidate specific pathophysiological mechanisms that contribute to dementia phenotypes and neuropathological causes has been proposed [37].”
BackgroundMetabolic network failures in Alzheimer's disease: A biochemical road map
Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.020 · Cited by 468
Self-citationNeuropathology of Alzheimer's Disease
Trejo-Lopez, J. A., Yachnis, A. T., & Prokop, S. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01146-y · Cited by 378
Metadata
- Authors
- Kling, M. A., Trojanowski, J. Q., Wolk, D. A., Lee, V. M. Y., & Arnold, S. E.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2012-11-26
- Volume
- 9
- Issue
- 1
- Pages
- 76-92
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W1994814164
- Cited by
- 133
- References
- 50
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Alzheimer's Diseases Coordinating Center
- NIH (P30 AG010124)
- Allen H. and Selma W. Berkman Charitable Trust
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vascular disease and dementias: Paradigm shifts to drive research in new directions. https://app.cochat.ai/papers/10.1016/j.jalz.2012.02.007
- The paper
- Kling, M. A., Trojanowski, J. Q., Wolk, D. A., Lee, V. M. Y., & Arnold, S. E. (2013). Vascular disease and dementias: Paradigm shifts to drive research in new directions. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2012.02.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.